![](/etc.clientlibs/bdb-aem/clientlibs/clientlib-base/resources/icons/blankimage.png)
-
Account Support
-
Contact
-
Technicalsupport
-
TrainingPage
-
TextAndDownloadTest
-
Protocol Details
-
Protocol Library Component
-
Multi-coloredtablecomponent
-
BDB Protocol Library
-
First Protocol Detail
-
Second Protocol Detail
-
Third Protocol Detail
-
Fourth Protocol Detail
- TrainingDetails
-
RewardsLandingPage
-
TrainingLandingPage
-
Technical Support
-
Bulletpointspage
-
PrivacyPolicy
-
Freeformcomponent
-
Account FAQs
-
Contact
Old Browser
References
1. Malouf C, Ottersbach K. Molecular processes involved in B cell acute lymphoblastic leukaemia. Cell Mol Life Sci. 2018;75(3):417-446. doi:10.1007/s00018-017-2620-z
2. Jiang M, Bennani MN, Feldman AL. Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas and histiocytic/dendritic cell neoplasms. Expert Rev Hematol. 2017;10(3):239-249. doi: 10.1080/17474086.2017.1281122
3. Küppers R, Hansmann ML. The Hodgkin and Reed/Sternberg cell. Int J Biochem Cell Biol. 2005;37(3):511-517. doi:10.1016/j.biocel.2003.10.025
4. Zeng Q, Schwarz H. The role of trogocytosis in immune surveillance of Hodgkin lymphoma. Oncoimmunology. 2020;9(1):1781334. doi:10.1080/2162402X.2020.1781334
5. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-2390. doi:10.1182/blood-2016-01-643569
BD flow cytometers are Class 1 Laser Products.
BD Biosciences clinical flow cytometry solutions, including instrumentation, software and reagents, offer the building blocks for laboratory-developed tests used in the identification of markers associated with cancers. These solutions are not FDA cleared or approved for the diagnosis of cancers. Analyte Specific Reagent. Analytical and performance characteristics are not established.
23-23021-00
Report a Site Issue
This form is intended to help us improve our website experience. For other support, please visit our Contact Us page.